Gabapentin improves parosmia after COVID-19 infection

Int Forum Allergy Rhinol. 2023 Jun;13(6):1034-1036. doi: 10.1002/alr.23117. Epub 2022 Dec 15.

Authors

Jaime A Pena Garcia¹, Emily Miller¹, Timothy G Norwood¹, Natalie A Dorin¹, Jessica Grayson¹, Bradford Woodworth^{1

2}, Do-Yeon Cho^{1

2

3}

Affiliations

¹ Department of Otolaryngology Head & Neck Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
² Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.
³ Division of Otolaryngology, Department of Surgery, Veterans Affairs, Birmingham, Alabama, USA.

No abstract available

Keywords: COVID19; coronavirus 2019; gabapentin; olfaction; olfactory dysfunction; parosmia; smell Loss.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

COVID-19*
Gabapentin / therapeutic use
Humans
Olfaction Disorders*
Smell

Substances

Gabapentin

Grants and funding